Am. J. Respir. Crit. Care Med., Vol 152, No. 6, Dec 1995, 2111-2118.
Inflammatory cytokines in cystic fibrosis lungs [published erratum appears in Am J Respir Crit Care Med 1996 Oct;154(4 Pt 1):following 1217]
TL Bonfield, JR Panuska, MW Konstan, KA Hilliard, JB Hilliard, H Ghnaim and M Berger
Department of Pediatrics, Case Western Reserve University, Cleveland, Ohio, USA.
Chronic pulmonary infection with Pseudomonas aeruginosa continues to be the
major cause of morbidity and mortality in cystic fibrosis (CF). Several
characteristics of CF, including the excessive influx of neutrophils into
the airways, cachexia, and hyperglobulinemia, could reflect the effects of
cytokines, such as interleukin-1 (IL-1), IL-6, IL-8, and tumor necrosis
factor (TNF-alpha). We hypothesized that these pro-inflammatory cytokines,
produced by alveolar macrophages in response to pseudomonas and/or other
microorganisms, promote the destructive inflammatory process in the lung.
We evaluated bronchoalveolar lavage (BAL) fluid and BAL macrophages from 22
CF patients and 13 healthy control (HC) subjects, measuring soluble TNF-
alpha, IL-1 beta, IL-6, and IL-8 and the regulatory molecules TNF soluble
receptor (TNF-sR), IL-1 receptor antagonist (IL-1Ra), and IL-10 (cytokine
synthesis inhibitory factor). Levels of the proinflammatory cytokines were
higher in CF versus HC BAL (p < or = 0.05 for IL-1, TNF, and IL-8; p =
0.06 for IL-6). In contrast, HC BAL contained significantly more IL-10 than
CF BAL (p < 0.05), but TNF-sR and IL-1Ra were similar.
Immunocytochemistry demonstrated a higher percentage of CF than control BAL
macrophages expressing intracellular cytokines (p < 0.05). Thus,
enhanced macrophage production of proinflammatory cytokines and decreased
production of the regulatory molecule IL-10 may have important roles in the
pathogenesis of CF lung disease.
This article has been cited by other articles:

|
 |

|
 |
 
M. Meyer, F. Huaux, X. Gavilanes, S. van den Brule, P. Lebecque, S. Lo Re, D. Lison, B. Scholte, P. Wallemacq, and T. Leal
Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis
Am. J. Respir. Cell Mol. Biol.,
November 1, 2009;
41(5):
590 - 602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Yu, Y. H. Zeidan, B. X. Wu, R. W. Jenkins, T. R. Flotte, Y. A. Hannun, and I. Virella-Lowell
Defective Acid Sphingomyelinase Pathway with Pseudomonas aeruginosa Infection in Cystic Fibrosis
Am. J. Respir. Cell Mol. Biol.,
September 1, 2009;
41(3):
367 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Bartling and M. L. Drumm
Loss of CFTR results in reduction of histone deacetylase 2 in airway epithelial cells
Am J Physiol Lung Cell Mol Physiol,
July 1, 2009;
297(1):
L35 - L43.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Balakathiresan, S. Bhattacharyya, U. Gutti, R. P. Long, C. Jozwik, W. Huang, M. Srivastava, H. B. Pollard, and R. Biswas
Tristetraprolin regulates IL-8 mRNA stability in cystic fibrosis lung epithelial cells
Am J Physiol Lung Cell Mol Physiol,
June 1, 2009;
296(6):
L1012 - L1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. R. Bartling and M. L. Drumm
Oxidative Stress Causes IL8 Promoter Hyperacetylation in Cystic Fibrosis Airway Cell Models
Am. J. Respir. Cell Mol. Biol.,
January 1, 2009;
40(1):
58 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Griese, M. Kappler, A. Gaggar, and D. Hartl
Inhibition of airway proteases in cystic fibrosis lung disease
Eur. Respir. J.,
September 1, 2008;
32(3):
783 - 795.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Koller, M. Kappler, P. Latzin, A. Gaggar, M. Schreiner, S. Takyar, M. Kormann, M. Kabesch, D. Roos, M. Griese, et al.
TLR Expression on Neutrophils at the Pulmonary Site of Infection: TLR1/TLR2-Mediated Up-Regulation of TLR5 Expression in Cystic Fibrosis Lung Disease
J. Immunol.,
August 15, 2008;
181(4):
2753 - 2763.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Owens, K. R. Shroyer, and T. T. Kingdom
Expression of Cyclooxygenase and Lipoxygenase Enzymes in Sinonasal Mucosa of Patients With Cystic Fibrosis
Arch Otolaryngol Head Neck Surg,
August 1, 2008;
134(8):
825 - 831.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Bezzerri, M. Borgatti, E. Nicolis, I. Lampronti, M. C. Dechecchi, I. Mancini, P. Rizzotti, R. Gambari, and G. Cabrini
Transcription Factor Oligodeoxynucleotides to NF-{kappa}B Inhibit Transcription of IL-8 in Bronchial Cells
Am. J. Respir. Cell Mol. Biol.,
July 1, 2008;
39(1):
86 - 96.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. S. Murphy, V. Sundareshan, T. J. Cory, D. Hayes Jr, M. I. Anstead, and D. J. Feola
Azithromycin alters macrophage phenotype
J. Antimicrob. Chemother.,
March 1, 2008;
61(3):
554 - 560.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Fuschillo, A. De Felice, and G. Balzano
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms
Eur. Respir. J.,
February 1, 2008;
31(2):
396 - 406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Caraher, J. Collins, G. Herbert, P. G. Murphy, C. G. Gallagher, M. J. Crowe, M. Callaghan, and S. McClean
Evaluation of in vitro virulence characteristics of the genus Pandoraea in lung epithelial cells
J. Med. Microbiol.,
January 1, 2008;
57(1):
15 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. N Hilliard, N. Regamey, J. K Shute, A. G Nicholson, E. W F W Alton, A. Bush, and J. C Davies
Airway remodelling in children with cystic fibrosis
Thorax,
December 1, 2007;
62(12):
1074 - 1080.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ostrowska, E. Sokolova, and G. Reiser
PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release
Am J Physiol Lung Cell Mol Physiol,
November 1, 2007;
293(5):
L1208 - L1218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. McMorran, S. A. Ouvry Patat, J. B. Carlin, K. Grimwood, A. Jones, D. S. Armstrong, J. C. Galati, P. J. Cooper, C. A. Byrnes, P. W. Francis, et al.
Novel Neutrophil-Derived Proteins in Bronchoalveolar Lavage Fluid Indicate an Exaggerated Inflammatory Response in Pediatric Cystic Fibrosis Patients
Clin. Chem.,
October 1, 2007;
53(10):
1782 - 1791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Sagel, J. F. Chmiel, and M. W. Konstan
Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease
Proceedings of the ATS,
August 1, 2007;
4(4):
406 - 417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Saadane, S. Masters, J. DiDonato, J. Li, and M. Berger
Parthenolide Inhibits I{kappa}B Kinase, NF-{kappa}B Activation, and Inflammatory Response in Cystic Fibrosis Cells and Mice
Am. J. Respir. Cell Mol. Biol.,
June 1, 2007;
36(6):
728 - 736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. DeBoer, X. X. Zhu, P. Levasseur, M. M. Meguid, S. Suzuki, A. Inui, J. E. Taylor, H. A. Halem, J. Z. Dong, R. Datta, et al.
Ghrelin Treatment Causes Increased Food Intake and Retention of Lean Body Mass in a Rat Model of Cancer Cachexia
Endocrinology,
June 1, 2007;
148(6):
3004 - 3012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Imamura, K. Yanagihara, Y. Fukuda, Y. Kaneko, M. Seki, K. Izumikawa, Y. Miyazaki, Y. Hirakata, T. Sawa, J. P. Wiener-Kronish, et al.
Effect of anti-PcrV antibody in a murine chronic airway Pseudomonas aeruginosa infection model
Eur. Respir. J.,
May 1, 2007;
29(5):
965 - 968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Dechecchi, E. Nicolis, V. Bezzerri, A. Vella, M. Colombatti, B. M. Assael, Y. Mettey, M. Borgatti, I. Mancini, R. Gambari, et al.
MPB-07 Reduces the Inflammatory Response to Pseudomonas aeruginosa in Cystic Fibrosis Bronchial Cells
Am. J. Respir. Cell Mol. Biol.,
May 1, 2007;
36(5):
615 - 624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Reiniger, M. M. Lee, F. T. Coleman, C. Ray, D. E. Golan, and G. B. Pier
Resistance to Pseudomonas aeruginosa Chronic Lung Infection Requires Cystic Fibrosis Transmembrane Conductance Regulator-Modulated Interleukin-1 (IL-1) Release and Signaling through the IL-1 Receptor
Infect. Immun.,
April 1, 2007;
75(4):
1598 - 1608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H Goss and J. L Burns
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Thorax,
April 1, 2007;
62(4):
360 - 367.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cigana, B. M. Assael, and P. Melotti
Azithromycin Selectively Reduces Tumor Necrosis Factor Alpha Levels in Cystic Fibrosis Airway Epithelial Cells
Antimicrob. Agents Chemother.,
March 1, 2007;
51(3):
975 - 981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Vos, N. A. Datson, K. F. Rabe, and P. S. Hiemstra
Exploring host-pathogen interactions at the epithelial surface: application of transcriptomics in lung biology
Am J Physiol Lung Cell Mol Physiol,
February 1, 2007;
292(2):
L367 - L377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Dubin and J. K. Kolls
IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice
Am J Physiol Lung Cell Mol Physiol,
February 1, 2007;
292(2):
L519 - L528.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Blau, K. Klein, I. Shalit, D. Halperin, and I. Fabian
Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-{kappa}B activation in a cystic fibrosis epithelial cell line
Am J Physiol Lung Cell Mol Physiol,
January 1, 2007;
292(1):
L343 - L352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Hays and J. V. Fahy
Characterizing Mucous Cell Remodeling in Cystic Fibrosis: Relationship to Neutrophils
Am. J. Respir. Crit. Care Med.,
November 1, 2006;
174(9):
1018 - 1024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Starosta, F. Ratjen, E. Rietschel, K. Paul, and M. Griese
Anti-inflammatory cytokines in cystic fibrosis lung disease
Eur. Respir. J.,
September 1, 2006;
28(3):
581 - 587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. B. Pollard, O. Eidelman, C. Jozwik, W. Huang, M. Srivastava, X. D. Ji, B. McGowan, C. F. Norris, T. Todo, T. Darling, et al.
De Novo Biosynthetic Profiling of High Abundance Proteins in Cystic Fibrosis Lung Epithelial Cells
Mol. Cell. Proteomics,
September 1, 2006;
5(9):
1628 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cuzick, F. R. Stirling, S. L. Lindsay, and T. J. Evans
The Type III Pseudomonal Exotoxin U Activates the c-Jun NH2-Terminal Kinase Pathway and Increases Human Epithelial Interleukin-8 Production
Infect. Immun.,
July 1, 2006;
74(7):
4104 - 4113.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Delgado, J. F. Poschet, and V. Deretic
Nonclassical Pathway of Pseudomonas aeruginosa DNA-Induced Interleukin-8 Secretion in Cystic Fibrosis Airway Epithelial Cells.
Infect. Immun.,
May 1, 2006;
74(5):
2975 - 2984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, W. Wang, W. Parker, and J. P. Clancy
Adenosine Regulation of Cystic Fibrosis Transmembrane Conductance Regulator through Prostenoids in Airway Epithelia
Am. J. Respir. Cell Mol. Biol.,
May 1, 2006;
34(5):
600 - 608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Lu, A. Hisatsune, T. Koga, K. Kato, I. Kuwahara, E. P. Lillehoj, W. Chen, A. S. Cross, S. J. Gendler, A. T. Gewirtz, et al.
Cutting Edge: Enhanced Pulmonary Clearance of Pseudomonas aeruginosa by Muc1 Knockout Mice
J. Immunol.,
April 1, 2006;
176(7):
3890 - 3894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Serisier, J. K. Shute, P. M. Hockey, B. Higgins, J. Conway, and M. P. Carroll
Inhaled heparin in cystic fibrosis
Eur. Respir. J.,
February 1, 2006;
27(2):
354 - 358.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shinkai, G. H. Foster, and B. K. Rubin
Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol,
January 1, 2006;
290(1):
L75 - L85.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Starner and P. B. McCray Jr.
Pathogenesis of Early Lung Disease in Cystic Fibrosis: A Window of Opportunity To Eradicate Bacteria
Ann Intern Med,
December 6, 2005;
143(11):
816 - 822.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Beringer, K. M. T. Huynh, J. Kriengkauykiat, L. Bi, N. Hoem, S. Louie, E. Han, T. Nguyen, D. Hsu, P. A. Rao, et al.
Absolute Bioavailability and Intracellular Pharmacokinetics of Azithromycin in Patients with Cystic Fibrosis
Antimicrob. Agents Chemother.,
December 1, 2005;
49(12):
5013 - 5017.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Solic, J. Wilson, S. J. Wilson, and J. K. Shute
Endothelial Activation and Increased Heparan Sulfate Expression in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
October 1, 2005;
172(7):
892 - 898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Worgall, A. Heguy, K. Luettich, T. P. O'Connor, B.-G. Harvey, L. E. N. Quadri, and R. G. Crystal
Similarity of Gene Expression Patterns in Human Alveolar Macrophages in Response to Pseudomonas aeruginosa and Burkholderia cepacia
Infect. Immun.,
August 1, 2005;
73(8):
5262 - 5268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A P Watt, J Courtney, J Moore, M Ennis, and J S Elborn
Neutrophil cell death, activation and bacterial infection in cystic fibrosis
Thorax,
August 1, 2005;
60(8):
659 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Yarden, D Radojkovic, K De Boeck, M Macek Jr, D Zemkova, V Vavrova, R Vlietinck, J-J Cassiman, and H Cuppens
Association of tumour necrosis factor alpha variants with the CF pulmonary phenotype
Thorax,
April 1, 2005;
60(4):
320 - 325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Allen, D. H. Dockrell, T. Pattery, D. G. Lee, P. Cornelis, P. G. Hellewell, and M. K. B. Whyte
Pyocyanin Production by Pseudomonas aeruginosa Induces Neutrophil Apoptosis and Impairs Neutrophil-Mediated Host Defenses In Vivo
J. Immunol.,
March 15, 2005;
174(6):
3643 - 3649.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Joseph, D. Look, and T. Ferkol
NF-{kappa}B activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa
Am J Physiol Lung Cell Mol Physiol,
March 1, 2005;
288(3):
L471 - L479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Sakamoto, H. Mukae, T. Fujii, H. Ishii, S. Yoshioka, T. Kakugawa, K. Sugiyama, Y. Mizuta, J.-i. Kadota, M. Nakazato, et al.
Differential effects of {alpha}- and {beta}-defensin on cytokine production by cultured human bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol,
March 1, 2005;
288(3):
L508 - L513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Agusti, A Rano, M Rovira, X Filella, N Benito, A Moreno, and A Torres
Inflammatory response associated with pulmonary complications in non-HIV immunocompromised patients
Thorax,
December 1, 2004;
59(12):
1081 - 1088.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Koehler, G. P. Downey, N. B. Sweezey, A. K. Tanswell, and J. Hu
Lung Inflammation as a Therapeutic Target in Cystic Fibrosis
Am. J. Respir. Cell Mol. Biol.,
October 1, 2004;
31(4):
377 - 381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Zaman, A. Gelrud, O. Junaidi, M. M. Regan, M. Warny, J. C. Shea, C. Kelly, B. P. O'Sullivan, and S. D. Freedman
Interleukin 8 Secretion from Monocytes of Subjects Heterozygous for the {Delta}F508 Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutation Is Altered
Clin. Vaccine Immunol.,
September 1, 2004;
11(5):
819 - 824.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Firoved, W. Ornatowski, and V. Deretic
Microarray Analysis Reveals Induction of Lipoprotein Genes in Mucoid Pseudomonas aeruginosa: Implications for Inflammation in Cystic Fibrosis
Infect. Immun.,
September 1, 2004;
72(9):
5012 - 5018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Lee, H. L. Elmer, K. R. Ross, and T. J. Kelley
Isoprenoid-Mediated Control of SMAD3 Expression in a Cultured Model of Cystic Fibrosis Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
August 1, 2004;
31(2):
234 - 240.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C S Haworth, P L Selby, A K Webb, L Martin, J S Elborn, L D Sharples, and J E Adams
Inflammatory related changes in bone mineral content in adults with cystic fibrosis
Thorax,
July 1, 2004;
59(7):
613 - 617.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Muir, G. Soong, S. Sokol, B. Reddy, M. I. Gomez, A. van Heeckeren, and A. Prince
Toll-Like Receptors in Normal and Cystic Fibrosis Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
June 1, 2004;
30(6):
777 - 783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Srivastava, O. Eidelman, J. Zhang, C. Paweletz, H. Caohuy, Q. Yang, K. A. Jacobson, E. Heldman, W. Huang, C. Jozwik, et al.
Digitoxin mimics gene therapy with CFTR and suppresses hypersecretion of IL-8 from cystic fibrosis lung epithelial cells
PNAS,
May 18, 2004;
101(20):
7693 - 7698.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Griese, J. Ramakers, A. Krasselt, V. Starosta, S. van Koningsbruggen, R. Fischer, F. Ratjen, B. Mullinger, R. M. Huber, K. Maier, et al.
Improvement of Alveolar Glutathione and Lung Function but Not Oxidative State in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
April 1, 2004;
169(7):
822 - 828.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Chatham, A.A. Ionescu, L.S. Nixon, and D.J. Shale
A short-term comparison of two methods of sputum expectoration in cystic fibrosis
Eur. Respir. J.,
March 1, 2004;
23(3):
435 - 439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dagenais, R. Frechette, Y. Yamagata, T. Yamagata, J.-F. Carmel, M.-E. Clermont, E. Brochiero, C. Masse, and Y. Berthiaume
Downregulation of ENaC activity and expression by TNF-{alpha} in alveolar epithelial cells
Am J Physiol Lung Cell Mol Physiol,
February 1, 2004;
286(2):
L301 - L311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Wine and N. S. Joo
Submucosal Glands and Airway Defense
Proceedings of the ATS,
January 1, 2004;
1(1):
47 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. L. Ordonez, N. R. Henig, N. Mayer-Hamblett, F. J. Accurso, J. L. Burns, J. F. Chmiel, C. L. Daines, R. L. Gibson, S. McNamara, G. Z. Retsch-Bogart, et al.
Inflammatory and Microbiologic Markers in Induced Sputum after Intravenous Antibiotics in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
December 15, 2003;
168(12):
1471 - 1475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Starner, C. K. Barker, H. P. Jia, Y. Kang, and P. B. McCray Jr.
CCL20 Is an Inducible Product of Human Airway Epithelia with Innate Immune Properties
Am. J. Respir. Cell Mol. Biol.,
November 1, 2003;
29(5):
627 - 633.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. L. Gibson, J. L. Burns, and B. W. Ramsey
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
October 15, 2003;
168(8):
918 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pinet, M. Cassart, P. Scillia, M. Lamotte, C. Knoop, G. Casimir, C. Melot, and M. Estenne
Function and Bulk of Respiratory and Limb Muscles in Patients with Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
October 15, 2003;
168(8):
989 - 994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ahmad, D. L. Bayley, S. He, and R. A. Stockley
Myeloid Related Protein-8/14 Stimulates Interleukin-8 Production in Airway Epithelial Cells
Am. J. Respir. Cell Mol. Biol.,
October 1, 2003;
29(4):
523 - 530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.M. Jones, L. Martin, R.J. Bright-Thomas, M.E. Dodd, A McDowell, K.L. Moffitt, J.S. Elborn, and A.K. Webb
Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa
Eur. Respir. J.,
September 1, 2003;
22(3):
503 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Song, H. Wu, O. Ciofu, K.-F. Kong, N. Hoiby, J. Rygaard, A. Kharazmi, and K. Mathee
Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection
J. Med. Microbiol.,
September 1, 2003;
52(9):
731 - 740.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Corvol, C. Fitting, K. Chadelat, J. Jacquot, O. Tabary, M. Boule, J.-M. Cavaillon, and A. Clement
Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis
Am J Physiol Lung Cell Mol Physiol,
June 1, 2003;
284(6):
L997 - L1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N.R. Labiris, C. Nahmias, A.P. Freitag, M.L. Thompson, and M.B. Dolovich
Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?
Eur. Respir. J.,
May 1, 2003;
21(5):
848 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Firoved and V. Deretic
Microarray Analysis of Global Gene Expression in Mucoid Pseudomonas aeruginosa
J. Bacteriol.,
February 1, 2003;
185(3):
1071 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Arkwright, V. Pravica, P. J. Geraghty, M. Super, A. K. Webb, M. Schwarz, and I. V. Hutchinson
End-Organ Dysfunction in Cystic Fibrosis: Association with Angiotensin I Converting Enzyme and Cytokine Gene Polymorphisms
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
384 - 389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, X. D. Johnson, S. Iazvovskaia, A. Tan, A. Lin, and M. B. Hershenson
Signaling intermediates required for NF-kappa B activation and IL-8 expression in CF bronchial epithelial cells
Am J Physiol Lung Cell Mol Physiol,
February 1, 2003;
284(2):
L307 - L315.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Aldallal, E. E. McNaughton, L. J. Manzel, A. M. Richards, J. Zabner, T. W. Ferkol, and D. C. Look
Inflammatory Response in Airway Epithelial Cells Isolated from Patients with Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
November 1, 2002;
166(9):
1248 - 1256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, S. Kartha, S. Iasvovskaia, A. Tan, R. K. Bhat, J. M. Manaligod, K. Page, A. R. Brasier, and M. B. Hershenson
Regulation of human airway epithelial cell IL-8 expression by MAP kinases
Am J Physiol Lung Cell Mol Physiol,
October 1, 2002;
283(4):
L690 - L699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C S Haworth, P L Selby, A W Horrocks, E B Mawer, J E Adams, and A K Webb
A prospective study of change in bone mineral density over one year in adults with cystic fibrosis
Thorax,
August 1, 2002;
57(8):
719 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Oceandy, B. J. McMorran, S. N. Smith, R. Schreiber, K. Kunzelmann, E. W.F.W. Alton, D. A. Hume, and B. J. Wainwright
Gene complementation of airway epithelium in the cystic fibrosis mouse is necessary and sufficient to correct the pathogen clearance and inflammatory abnormalities
Hum. Mol. Genet.,
May 1, 2002;
11(9):
1059 - 1067.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Venarske and R. D. deShazo
Sinobronchial Allergic Mycosis* : The SAM Syndrome
Chest,
May 1, 2002;
121(5):
1670 - 1676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Chmiel, M. W. Konstan, A. Saadane, J. E. Krenicky, H. Lester Kirchner, and M. Berger
Prolonged Inflammatory Response to Acute Pseudomonas Challenge in Interleukin-10 Knockout Mice
Am. J. Respir. Crit. Care Med.,
April 15, 2002;
165(8):
1176 - 1181.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Epelman, G. G. Neely, L. L. Ma, M. Gjomarkaj, E. Pace, M. Melis, D. E. Woods, and C. H. Mody
Distinct fates of monocytes and T cells directly activated by Pseudomonas aeruginosa exoenzyme S
J. Leukoc. Biol.,
March 1, 2002;
71(3):
458 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Firoved, J. C. Boucher, and V. Deretic
Global Genomic Analysis of AlgU ({sigma}E)-Dependent Promoters (Sigmulon) in Pseudomonas aeruginosa and Implications for Inflammatory Processes in Cystic Fibrosis
J. Bacteriol.,
February 15, 2002;
184(4):
1057 - 1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Soltys, T. Bonfield, J. Chmiel, and M. Berger
Functional IL-10 Deficiency in the Lung of Cystic Fibrosis (cftr-/-) and IL-10 Knockout Mice Causes Increased Expression and Function of B7 Costimulatory Molecules on Alveolar Macrophages
J. Immunol.,
February 15, 2002;
168(4):
1903 - 1910.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. De Rose
Mechanisms and markers of airway inflammation in cystic fibrosis
Eur. Respir. J.,
February 1, 2002;
19(2):
333 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Delmotte, S. Degroote, J.-J. Lafitte, G. Lamblin, J.-M. Perini, and P. Roussel
Tumor Necrosis Factor alpha Increases the Expression of Glycosyltransferases and Sulfotransferases Responsible for the Biosynthesis of Sialylated and/or Sulfated Lewis x Epitopes in the Human Bronchial Mucosa
J. Biol. Chem.,
January 4, 2002;
277(1):
424 - 431.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. ANGRILL, C. AGUSTI, R. DE CELIS, X. FILELLA, A. RANO, M. ELENA, J. P. DE LA BELLACASA, A. XAUBET, and A. TORRES
Bronchial Inflammation and Colonization in Patients with Clinically Stable Bronchiectasis
Am. J. Respir. Crit. Care Med.,
November 1, 2001;
164(9):
1628 - 1632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Hardin, A. Leblanc, G. Marshall, and D. K. Seilheimer
Mechanisms of insulin resistance in cystic fibrosis
Am J Physiol Endocrinol Metab,
November 1, 2001;
281(5):
E1022 - E1028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. SAGEL, R. KAPSNER, I. OSBERG, M. K. SONTAG, and F. J. ACCURSO
Airway Inflammation in Children with Cystic Fibrosis and Healthy Children Assessed by Sputum Induction
Am. J. Respir. Crit. Care Med.,
October 15, 2001;
164(8):
1425 - 1431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Hardin, K. J. Ellis, M. Dyson, J. Rice, R. McConnell, and D. K. Seilheimer
Growth Hormone Decreases Protein Catabolism in Children with Cystic Fibrosis
J. Clin. Endocrinol. Metab.,
September 1, 2001;
86(9):
4424 - 4428.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Chanson, P.-Y. Berclaz, I. Scerri, T. Dudez, K. Wernke-Dollries, L. Pizurki, A. Pavirani, M. A. Fiedler, and S. Suter
Regulation of Gap Junctional Communication by a Pro-Inflammatory Cytokine in Cystic Fibrosis Transmembrane Conductance Regulator-Expressing but Not Cystic Fibrosis Airway Cells
Am. J. Pathol.,
May 1, 2001;
158(5):
1775 - 1784.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K Lark, G. E Lester, D. A Ontjes, A. D Blackwood, B. W Hollis, M. M Hensler, and R. M Aris
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients
Am. J. Clinical Nutrition,
March 1, 2001;
73(3):
602 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marchand, C. Verellen-Dumoulin, M. Mairesse, L. Delaunois, P. Brancaleone, J.-F. Rahier, and O. Vandenplas
Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations and 5T Allele in Patients With Allergic Bronchopulmonary Aspergillosis
Chest,
March 1, 2001;
119(3):
762 - 767.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ledson, M. Gallagher, C.A. Hart, and M. Walshaw
Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients
Eur. Respir. J.,
January 1, 2001;
17(1):
36 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. ARIS, A. R. STEPHENS, D. A. ONTJES, A. DENENE BLACKWOOD, R. K. LARK, M. B. HENSLER, I. P. NEURINGER, and G. E. LESTER
Adverse Alterations in Bone Metabolism Are Associated with Lung Infection in Adults with Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
November 1, 2000;
162(5):
1674 - 1678.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. Van der Vliet, M. N. Nguyen, M. K. Shigenaga, J. P. Eiserich, G. P. Marelich, and C. E. Cross
Myeloperoxidase and protein oxidation in cystic fibrosis
Am J Physiol Lung Cell Mol Physiol,
September 1, 2000;
279(3):
L537 - L546.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Clemans, R. J. Bauer, J. A. Hanson, M. V. Hobbs, J. W. St. Geme III, C. F. Marrs, and J. R. Gilsdorf
Induction of Proinflammatory Cytokines from Human Respiratory Epithelial Cells after Stimulation by Nontypeable Haemophilus influenzae
Infect. Immun.,
August 1, 2000;
68(8):
4430 - 4440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Epelman, T. F. Bruno, G. G. Neely, D. E. Woods, and C. H. Mody
Pseudomonas aeruginosa Exoenzyme S Induces Transcriptional Expression of Proinflammatory Cytokines and Chemokines
Infect. Immun.,
August 1, 2000;
68(8):
4811 - 4814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. V. Galietta, C. Folli, C. Marchetti, L. Romano, D. Carpani, M. Conese, and O. Zegarra-Moran
Modification of transepithelial ion transport in human cultured bronchial epithelial cells by interferon-gamma
Am J Physiol Lung Cell Mol Physiol,
June 1, 2000;
278(6):
L1186 - L1194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Cowley, K. Govindaraju, C. Guilbault, D. Radzioch, and D. H. Eidelman
Airway surface liquid composition in mice
Am J Physiol Lung Cell Mol Physiol,
June 1, 2000;
278(6):
L1213 - L1220.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. L Smyth, N. M Croft, U. O'Hea, T. G Marshall, and A. Ferguson
Intestinal inflammation in cystic fibrosis
Arch. Dis. Child.,
May 1, 2000;
82(5):
394 - 399.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Yu, S. Z. Nasr, and V. Deretic
Innate Lung Defenses and Compromised Pseudomonas aeruginosa Clearance in the Malnourished Mouse Model of Respiratory Infections in Cystic Fibrosis
Infect. Immun.,
April 1, 2000;
68(4):
2142 - 2147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Thomas, S. A. Kharitonov, S. F. Scott, M. E. Hodson, and P. J. Barnes
Nasal and Exhaled Nitric Oxide Is Reduced in Adult Patients With Cystic Fibrosis and Does Not Correlate With Cystic Fibrosis Genotype
Chest,
April 1, 2000;
117(4):
1085 - 1089.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Thomas, E. A. Costelloe, D. P. Lunn, K. J. Stacey, S. J. Delaney, R. Passey, E. C. McGlinn, B. J. McMorran, A. Ahadizadeh, C. L. Geczy, et al.
G551D Cystic Fibrosis Mice Exhibit Abnormal Regulation of Inflammation in Lungs and Macrophages
J. Immunol.,
April 1, 2000;
164(7):
3870 - 3877.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Taggart, R. J. Coakley, P. Greally, G. Canny, S. J. O'Neill, and N. G. McElvaney
Increased elastase release by CF neutrophils is mediated by tumor necrosis factor-alpha and interleukin-8
Am J Physiol Lung Cell Mol Physiol,
January 1, 2000;
278(1):
L33 - L41.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1995 American Thoracic Society
|
|
|